2009•Unpublished venueRequires access

Enhanced efficacy of the use of a monovalent infectious bronchitis virus inactivated vaccine in layers primed with H120 and 793B live IBV vaccines to increase the protection against challenge with 3 European serotypes of IBV.

Janneke Wit, H. van de Sande, Francesco Prandini, Ursula Heffels-Redmann, Dagmar Sommer, E. F. Kaleta

Open publisher page 3 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Virology, Infectious bronchitis virus, Attenuated vaccine, Medicine, Microbiology, Vaccination, Virus, Biology

Back to paper search Browse research topics Original source

Enhanced efficacy of the use of a monovalent infectious bronchitis virus inactivated vaccine in layers primed with H120 and 793B live IBV vaccines to increase the protection against challenge with 3 European serotypes of IBV. — Research Paper | ScholarLens